1Senbonmatsu T,Lichihara S,Univ V,etal.Angiotensin Ⅱ type 2 receptor(AT2)is essential for the development of cardiachypertrophy by pressure overload.Circulation,1999,100(18):1-625.
2Strawn WB,Chappe11 MC,Dean RH,et al.Inhibition of early atherogenesis by losartanin monkeys with diet-induced hypercholesterolemia.Circulation,2000,101(13):1586-1593.
3Nakashima H,Kamagai K,Gondo N,et al.Angiotensin Ⅱ type 1 receptor antagonistprevents electrical remodeling in atrial fibrillation.Circulation,1999,100(18):1-11.
4Goette A,Arndt M,Pocken C,et al.Regulation of angiotensin Ⅱ receptorsubtypes during atrial fibrillation in humans.Circulation,2000,101(23):2678-2681.
5Sweet Cs,Bradstreet DC,Berman Rs,et al.Pharmacodynamic activity of intravenousE-3174,an angiotensin Ⅱ antogonist,in patients with essential hypertension.Am JHypertens,1994,7(12):1035-1040.
6Burnier M,Waeber B,Brunner HR.Clinical pharmacology of the angiotensin Ⅱ receptorantagonist losartan potussium in healthy subjects.J hypertens,1995,13(Suppi I):523-528.
7Lau K,Stote RM,Goldbery M,Agus zs.Mechanisms of the uricosuric effect of thediuretic tienilic acid(ticrynafen)in man.Clin Sci Mol Med,1977,53(4):379-386.
8Nakashima M,Vematsa T.Kosuge K.Pilot study of the uricosuric effect of DVP-753,anew angiotensin Ⅱ receptor antagonist,in healthy subjects.Eur J Clinpharmacol,1992,42(3):333-335.
9Dickstein K.Angiotensin Ⅱ antagonists are superior to ACE inhibitors.Eur J HeartFail,2000,2(3):235-236.
10White HL,Hall AS,et al.‘ACE inhibitors are better than AT1 receptorblockers(ARBs)’-controversies in heart failure.Eur J Heart Fail,2000,2(3):237-240
4Ruilope LM,Schiffnin EL. Blood pressure control and benefits of antihypertensive therapy:does it make adiffcrence which agents we use[J]. Hypertension,2001,38 ( 3 ): 537-542.
5European Society of Hyertension - European Society of Cardiology Guidelines Committee.2003 European Society of Hypertension - European Society of Cardiology Guidelines for the management of arterial hypertcnsion[J].Hypertens, 2003,21 (6): 10-11.
6Ross A,Papademet riou V. Candesartan ci|exetil in cardiovascular disease[J]. Expert Rev Cardiovasc Ther, 2004, 2 ( 6 ) : 829-835.
7Johnston CL. Angiotensin receptor antagonists:focus on losartan[J]. Lancet, 2000,346: 1403-1407.
8Staessen JA, Fagard B. Randomised double blind comparison of placebo and active tretment for older patients with isolated systolic hypertebension. The systolic hypertension in Europe( systeur )trial investigators[J]. Lancet,1997,350 ( 9080 ) : 757-764.
9Hansson L, Zanchetti A, Carruthers SG. Efffects of intensive blood pressure lowering and tow-dose aspirin in patients with hypertenslon:principal results of the hypertension optimal treatment(HOT) randomized trial[J]. Lancet, 1998, 351 ( 9118 ) : 1755-1762.
10Urata H, Strobel F, Ganten D. Windespread tissue distribution of human ehymase. J Hypertens,1994, (12):17-19
